Group 6B: HER2-negative & BRCA+ Breast Cancer; Latin American Populations; Genetic Testing

Poster #PO1-16-06: LuciA-15 – A real-world prospective study of PARP inhibitors for the treatment of Latin American patients with HER-2 negative metastatic breast cancer with mutation of BRCA1/2 genes or in the homologous recombination repair genes.

Poster #PO1-08-08: Hereditary cancer genetic testing in Puerto Rican females.